I thought of an interesting thought. Compounding is our
I thought of an interesting thought. Compounding is our main engine right now and based upon last month our run rate is 49m in revenues. We also make a very small % on the DOD which is approx 3% per month but it is the govt. Thats about 30k per month. We also receive a few dollars about 23k in profits per month on wrx with no expenses for essentiially doing nothing. PIMD nothing yet but that should come around sooner than later. So currently 3 ACTIVE STREAMS OF REVENUE.
Ok. IF Rapimeds finally kicks in and takes off this will really start to get interesting. If we sustain 4m per month on compounding I believe we will net approx. 12.5% after everything is said and done IMHO. So thats 500k per month. With the DOD and WRX there is another 60k approx so we should see to the bottom line approx 560k and again this is my opinion. A little over 6 weeks agao Stock Legends did a radio interview with Bob S. Bob stated openly on the interview that he believes rapimeds will rival our flagship item compounding. This is directly from the ceo who certainly has a better scope on things than anybody else. I repeat he said rapimeds will rival compounding. Well that is a ringing endorsement of epic proportions. I will not predict rapimeds entrance into the market but it appears that rapimeds is very much on our plate. Frankly I am not concerned with why it has not started as we are well past that point. To simplify things we have something on the books called cash now 345k and that was before july when we did 4m ( imho I believe approx. 500k we receive) so all I know is once you have $$$$$$ you have a lot more leverage. I believe as our cash on hand grows the liklihood of rapimeds starting is far greater than it was with no cash. You can fill in the blanks and start guessing as to when. We are much healthier now than we have ever been as a company. Back in November when we were the same price at .09 cents we had all those toxic notes to contend with as well as the prospect of having no $$$$$$. Now at .09 cents fast forward 8 months we have cash on hands 345k ( probably over 700k with july) no more toxic notes written see oct 22nd Bob s's birthday, and a flourishing business in compounding. Guys/gals look at the picture November we were at .09 cents and august 2014 we are at .09 cents. Can you see what I see???? look at the company in November we had NOTHING BUT BELIEVING IN BOB AND HIS LEADERSHIP. And look at now In august we have a flourishing business with compounding that for 6 straight months has grown. I do not think much more all my opinion but look at how far we have come as a company. We are now in a very good spot as a company. The company HAS NEVER BEEN BETTER.
We have come a long way and it will be a November to Remember!
ScripsAmerica Inc (SCRC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Triple-negative is a heavy phrase to hand somebody without a map. Tigerlily Foundation and the Breast Cancer Resource Center are trying to close that gap with a national education campaign scheduled to launch publicly on January 11, 2027. The plan is straightforward on paper: train and mobilize 100 patient advocates across the country to explain triple-negative breast...
Continue Reading
A Guidance Gap That Cannot Be Shrugged Off A $0.20-per-share hole is a nasty thing to find after management said it could see the road ahead. Universal Technical Institute reported fiscal 2026 diluted earnings per share of $0.60, below the $0.71 to $0.80 range it reaffirmed on May 6. That is at least $0.11 under the low end and roughly 21% below the midpoint. For...
Continue Reading
A few minutes on the table can sound almost suspiciously brisk when somebody is dealing with a stiff neck, sore back, or nagging joint discomfort. Yet that is the central point in Dr. Craig Peterson's explanation for HelloNation: the adjustment itself may be brief, while the value of a chiropractor visit depends on a focused assessment, appropriate technique, and whether...
Continue Reading
A moon mission, a 360-voice choir, and Christmas television make an unusual bundle, but that is precisely why this year’s Tabernacle Choir special has some real staying power. Peace on Earth: Christmas with The Tabernacle Choir is not trying to chase whatever noisy trend is chewing up attention this week. It is building a 90-minute holiday event around Apollo 8,...
Continue Reading
A crowded family attraction map is a nice problem for a Texas city to have, and North Richland Hills is trying to turn that pile of assets into a cleaner regional tourism machine. On Nov. 20, 2026, the city introduced “The Place You Never Outgrow,” its first destination-marketing campaign, built with Flat Five Marketing. This is not a stock story in the usual...
Continue Reading
Seven years of courtroom smoke over an under-$80,000 lien is the sort of mess that makes any business owner grind his teeth. Palm Beach Polo says its president, Glenn Straub, has again prevailed against Jessica Nicodemo in Palm Beach County, following an earlier Broward County dismissal of related claims. The company also says Vice President Sal Spano received a directed...
Continue Reading
Federal procurement has a stubborn habit of sounding abstract until you remember that contracts can decide whether a small company hires, invests, or simply keeps the lights on. Senator Adam Schiff introduced the Women's Economic Fairness and Small Business Contracting Act on November 19, 2026, proposing to raise the federal goal for Women-Owned Small Businesses from 5%...
Continue Reading
A blister-pack code is doing far more work than it ever should. Green Lumber Holdings is recalling Green Lumber Natural Fuel For Men, lot GL01 with expiration 09/27, after FDA laboratory analysis confirmed undeclared tadalafil in additional samples. The company says the consumer-level recall begins November 19, 2026. This is not a cute labeling nitpick or a marketing...
Continue Reading
Two executives, one New York stage, and a short calendar gap give Restaurant Brands International a clean chance to address investors without the usual blizzard of quarterly slides. Chief Executive Officer Josh Kobza and Chief Financial Officer Sami Siddiqui are scheduled for a fireside chat at Morgan Stanley's Global Consumer & Retail Conference on December 2, 2026, at...
Continue Reading
A paper maker can survive plenty of ugly quarters; it cannot casually shrug off an auditor questioning whether it can keep operating. That is the cold part of IT Tech Packaging's Nov. 19 disclosure. Its newly filed Form 10-K for the year ended Dec. 31, 2025 carries a “Material Uncertainty Related to Going Concern” paragraph from Audit Alliance LLP. Nobody should dress...
Continue Reading
Top 5 Most Recently Viewed Articles
Pharvaris Highlights Clinical Progress in HAE Treatment At the recent AAAAI/WAO Joint Congress, Pharvaris presented compelling long-term clinical data supporting the use of deucrictibant, a novel oral treatment for hereditary angioedema (HAE). This data underscores the drug's potential to not only prevent but also effectively address HAE attacks, offering hope to those...
Continue Reading
First Horizon Unveils New Banking Center with Appalachian Spirit First Horizon Bank (NYSE: FHN) proudly celebrated the grand opening of its newly refreshed banking center. The location pays tribute to the vibrant Appalachian State community, showcasing a striking theme that reflects its strong ties with Appalachian State University and its athletics. This celebration...
Continue Reading
Innovative Research on Namodenoson’s Impact in Liver Cancer Therapy Namodenoson, developed by Can-Fite BioPharma Ltd., is making waves in the medical community as a promising candidate for liver cancer treatment. Unlike traditional chemotherapy, which often harms healthy cells, Namodenoson is lauded for its protective qualities towards normal body systems. Published...
Continue Reading
Geotab Enhances Public Sector Solutions with Technological Advancements Geotab Inc., a leader in connected vehicle solutions and asset management, has taken a major step forward in serving the public sector by expanding its cooperative purchasing contracts with Sourcewell and Canoe Procurement Group. This expansion introduces four cutting-edge solutions aimed at enhancing...
Continue Reading
Dun & Bradstreet Achieves TRUSTe Responsible AI Certification Dun & Bradstreet (NYSE:DNB), recognized globally as a leading provider of business decisioning data and analytics, has been awarded the TRUSTe Responsible AI Certification. This certification signifies the company’s commitment to ethical and responsible governance in the realm of artificial intelligence (AI)....
Continue Reading